FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

27623611000001100: Generic Viokase 16 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83789801000001116 Generic Viokase 16 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83789901000001110 Generic Viokase 16 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Generic Viokase 16 tablets Has specific active ingredient Protease true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Plays role Digestant therapeutic role false Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has specific active ingredient Protease false Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has specific active ingredient Protease false Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has specific active ingredient Amylase true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has specific active ingredient Lipase true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Is a Product containing pancreatin false Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has active ingredient Pancreatin false Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets Has specific active ingredient Substance with protease mechanism of action false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Viokase 16 tablets (Imported (Canada)) Is a True Generic Viokase 16 tablets Inferred relationship Existential restriction modifier
Generic Viokase 16 tablets 100 tablet Has VMP True Generic Viokase 16 tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start